ZOE.L
Zoetic International Plc [ZOE.L] Stock Forecast
Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
ZOE.L Stock Summary
In the News
ZOE.L Financial details
Company Rating
Neutral
Market Cap
0
Income
0
Revenue
0
Book val./share
-
Cash/share
-
Dividend
-
Dividend %
-
Employees
13
Optionable
No
Shortable
Yes
Earnings
28 Jan 2021
P/E
-748.18
Forward P/E
-
PEG
-
P/S
-
P/B
-19846.61
P/C
-
P/FCF
-
Quick Ratio
0.17
Current Ratio
0.89
Debt / Equity
-8.86
LT Debt / Equity
-0.32
-
-
EPS (TTM)
0
EPS next Y
-
EPS next Q
-
EPS this Y
-15.99%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
-
Revenue last 5Y
-
Revenue Q/Q
-
EPS Q/Q
-
-
-
-
-
SMA20
-
SMA50
-
SMA100
-
Inst Own
-
Inst Trans
-
ROA
-337%
ROE
-630%
ROC
38.77%
Gross Margin
-13%
Oper. Margin
-1838%
Profit Margin
-1853%
Payout
-
Shs Outstand
212.07M
Shs Float
138.52M
-
-
-
-
Target Price
-
52W Range
37.25-39
52W High
-3.53%
52W Low
+1.69%
RSI
-
Rel Volume
0.2
Avg Volume
941.49K
Volume
186.95K
Perf Week
0%
Perf Month
0%
Perf Quarter
0%
Perf Half Y
77.06%
-
-
-
-
Beta
1.5303
-
-
Volatility
0%, 0%
Prev Close
0%
Price
37.625
Change
-
ZOE.L Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2021-03-31
| Metric | History | 2017-03-31 | 2018-03-31 | 2019-03-31 | 2020-03-31 | 2021-03-31 |
|---|---|---|---|---|---|---|
| Revenue per share | 0 | 0.03 | 0.01 | 0 | 0 | |
| Net income per share | -0.07 | -0.04 | -0.05 | -0.06 | -0.05 | |
| Operating cash flow per share | -0.06 | -0.03 | -0.03 | -0.02 | -0.01 | |
| Free cash flow per share | -0.15 | -0.09 | -0.04 | -0.02 | -0.01 | |
| Cash per share | 0.04 | 0.01 | 0.01 | 0 | 0 | |
| Book value per share | 0.14 | 0.1 | 0.05 | 0.02 | 0 | |
| Tangible book value per share | 0.04 | 0.03 | 0.05 | 0.02 | 0 | |
| Share holders equity per share | 0.14 | 0.1 | 0.05 | 0.02 | 0 | |
| Interest debt per share | 0 | 0 | 0 | 0 | 0 | |
| Market cap | 0 | 0 | 0 | 0 | 0 | |
| Enterprise value | 0 | 0 | 0 | 0 | 0 | |
| P/E ratio | 0 | 0 | 0 | 0 | 0 | |
| Price to sales ratio | 0 | 0 | 0 | 0 | 0 | |
| POCF ratio | 0 | 0 | 0 | 0 | 0 | |
| PFCF ratio | 0 | 0 | 0 | 0 | 0 | |
| P/B Ratio | 0 | 0 | 0 | 0 | 0 | |
| PTB ratio | 0 | 0 | 0 | 0 | 0 | |
| EV to sales | 0 | 0 | 0 | 0 | 0 | |
| Enterprise value over EBITDA | 0 | 0 | 0 | 0 | 0 | |
| EV to operating cash flow | 0 | 0 | 0 | 0 | 0 | |
| EV to free cash flow | 0 | 0 | 0 | 0 | 0 | |
| Earnings yield | 0 | 0 | 0 | 0 | 0 | |
| Free cash flow yield | 0 | 0 | 0 | 0 | 0 | |
| Debt to equity | 0.05 | 0.29 | 0.21 | 0.58 | -8.86 | |
| Debt to assets | 0.04 | 0.22 | 0.17 | 0.37 | 1.13 | |
| Net debt to EBITDA | 0.59 | 0.2 | 0.28 | -0.04 | 0.04 | |
| Current ratio | 7.2 | 1.16 | 2.05 | 2.65 | 0.89 | |
| Interest coverage | 0 | 0 | 0 | 0 | 0 | |
| Income quality | 0.93 | 0.63 | 0.62 | 0.32 | 0.17 | |
| Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
| Payout ratio | 0 | 0 | 0 | 0 | 0 | |
| Sales general and administrative to revenue | 0 | 2.37 | 5.42 | 20.35 | 14.52 | |
| Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
| Intangibles to total assets | 0.68 | 0.55 | 0.06 | 0 | 0 | |
| Capex to operating cash flow | 1.41 | 2.37 | 0.4 | 0.07 | 0 | |
| Capex to revenue | 0 | -2.04 | -1.42 | -1.76 | 0 | |
| Capex to depreciation | -51.49 | -5.98 | -4.46 | -0.49 | -0.07 | |
| Stock based compensation to revenue | 0 | 0 | 0 | 0.44 | 7.81 | |
| Graham number | 0.46 | 0.3 | 0.24 | 0.16 | 0.05 | |
| ROIC | -1.03 | -0.4 | -1.01 | -0.73 | -7.8 | |
| Return on tangible assets | -1.45 | -0.74 | -0.8 | -2.12 | -3.37 | |
| Graham Net | 0.03 | -0.02 | 0 | 0 | -0.01 | |
| Working capital | 2M | 422.57K | 1.38M | 2.03M | -206.74K | |
| Tangible asset value | 2.01M | 2.67M | 5.88M | 2.11M | -224.18K | |
| Net current asset value | 2M | 422.57K | 1.38M | 2.03M | -278.78K | |
| Invested capital | 0 | 0 | 0 | 0.28 | -0.36 | |
| Average receivables | 0 | 0 | 0 | 0 | 0 | |
| Average payables | 92.94K | 584.35K | 566.44K | 129.64K | 224.59K | |
| Average inventory | 0 | 0 | 0 | 583.87K | 1.2M | |
| Days sales outstanding | 0 | 0 | 0 | 0 | 0 | |
| Days payables outstanding | 0 | 0 | 0 | 703.41 | 343.21 | |
| Days of inventory on hand | 0 | 0 | 0 | 7.52K | 1.25K | |
| Receivables turnover | 0 | 0 | 0 | 0 | 0 | |
| Payables turnover | 0 | 0 | 0 | 0.52 | 1.06 | |
| Inventory turnover | 0 | 0 | 0 | 0.05 | 0.29 | |
| ROE | -0.48 | -0.42 | -0.91 | -3.35 | 26.53 | |
| Capex per share | -0.09 | -0.06 | -0.01 | 0 | 0 |
Quarterly Fundamentals Overview
Last date of statement is 2021-03-31 for Q1
| Metric | History | 2020-01-31 | 2020-03-31 | 2020-06-30 | 2020-09-30 | 2021-03-31 |
|---|---|---|---|---|---|---|
| Revenue per share | 0 | 0 | 0 | 0 | 0 | |
| Net income per share | 0 | 0 | 0 | 0 | 0 | |
| Operating cash flow per share | 0 | 0 | 0 | 0 | 0 | |
| Free cash flow per share | 0 | 0 | 0 | 0 | 0 | |
| Cash per share | 0 | 0 | 0 | 0 | 0 | |
| Book value per share | 0 | 0 | 0 | 0 | 0 | |
| Tangible book value per share | 0 | 0 | 0 | 0 | 0 | |
| Share holders equity per share | 0 | 0 | 0 | 0 | 0 | |
| Interest debt per share | 0 | 0 | 0 | 0 | 0 | |
| Market cap | 0 | 0 | 0 | 0 | 0 | |
| Enterprise value | 0 | 0 | 0 | 0 | 0 | |
| P/E ratio | 0 | 0 | 0 | 0 | 0 | |
| Price to sales ratio | 0 | 0 | 0 | 0 | 0 | |
| POCF ratio | 0 | 0 | 0 | 0 | 0 | |
| PFCF ratio | 0 | 0 | 0 | 0 | 0 | |
| P/B Ratio | 0 | 0 | 0 | 0 | 0 | |
| PTB ratio | 0 | 0 | 0 | 0 | 0 | |
| EV to sales | 0 | 0 | 0 | 0 | 0 | |
| Enterprise value over EBITDA | 0 | 0 | 0 | 0 | 0 | |
| EV to operating cash flow | 0 | 0 | 0 | 0 | 0 | |
| EV to free cash flow | 0 | 0 | 0 | 0 | 0 | |
| Earnings yield | 0 | 0 | 0 | 0 | 0 | |
| Free cash flow yield | 0 | 0 | 0 | 0 | 0 | |
| Debt to equity | 0 | 0.58 | 0 | 0.7 | -8.86 | |
| Debt to assets | 0 | 0.37 | 0 | 0.41 | 1.13 | |
| Net debt to EBITDA | 0 | 0 | 0 | 0 | 0 | |
| Current ratio | 0 | 2.65 | 0 | 3.14 | 0.89 | |
| Interest coverage | 0 | 0 | 0 | 0 | 0 | |
| Income quality | 0.32 | 0.32 | 0.32 | 0.32 | 0 | |
| Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
| Payout ratio | 0 | 0 | 0 | 0 | 0 | |
| Sales general and administrative to revenue | 0 | 0 | 0 | 0 | 0 | |
| Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
| Intangibles to total assets | 0 | 0 | 0 | 0 | 0 | |
| Capex to operating cash flow | 0.07 | 0.07 | 0.07 | 0.07 | 0 | |
| Capex to revenue | 0 | 0 | 0 | 0 | 0 | |
| Capex to depreciation | -0.49 | -0.49 | -0.49 | -0.49 | 0 | |
| Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
| Graham number | 0 | 0 | 0 | 0 | 0 | |
| ROIC | 0 | 0 | 0 | 0 | 0 | |
| Return on tangible assets | 0 | 0 | 0 | 0 | 0 | |
| Graham Net | 0 | 0 | 0 | 0 | 0 | |
| Working capital | 0 | 2.03M | 0 | 1.69M | -206.74K | |
| Tangible asset value | 0 | 2.11M | 0 | 1.49M | -224.18K | |
| Net current asset value | 0 | 2.03M | 0 | 1.42M | -278.78K | |
| Invested capital | 0 | 0.28 | 0 | 0.18 | -0.36 | |
| Average receivables | 0 | 0 | 0 | 0 | 0 | |
| Average payables | 0 | 0 | 0 | 0 | 0 | |
| Average inventory | 0 | 0 | 0 | 0 | 0 | |
| Days sales outstanding | 0 | 0 | 0 | 0 | 0 | |
| Days payables outstanding | 0 | 0 | 0 | 0 | 0 | |
| Days of inventory on hand | 0 | 0 | 0 | 0 | 0 | |
| Receivables turnover | 0 | 0 | 0 | 0 | 0 | |
| Payables turnover | 0 | 0 | 0 | 0 | 0 | |
| Inventory turnover | 0 | 0 | 0 | 0 | 0 | |
| ROE | 0 | 0 | 0 | 0 | 0 | |
| Capex per share | 0 | 0 | 0 | 0 | 0 |
ZOE.L Frequently Asked Questions
What is Zoetic International Plc stock symbol ?
Zoetic International Plc is a GB stock and trading under the symbol ZOE.L
What is Zoetic International Plc stock quote today ?
Zoetic International Plc stock price is $37.625 today.
Is Zoetic International Plc stock public?
Yes, Zoetic International Plc is a publicly traded company.
Company Profile
- Volume Average 941.49K
- Employee 13
- CEO Mr. Nick Tulloch
- Headquarters PERTH & KINROSS,GB
- IPO Date 2015-03-25
-
Website
http://zoeticinternational.com 
Zoetic International Plc, a vertically integrated CBD company, produces and sells CBD in the United States and the United Kingdom. The company also holds a 7.5% carried working interest in the Colorado Shale, which comprises eight wells located in East Denver. In addition, it holds interest in the Kansas Nitrogen; Enhanced Oil Recovery and Highlands Water Resources projects; and Montana project, a natural gas and helium deposit covering an area of approximately 154,072 acres in south Eastern Montana. The company was formerly known as Highlands Natural Resources plc and changed its name to Zoetic International Plc in September 2019. Zoetic International Plc was founded in 2014 and is headquartered in London, the United Kingdom.
